Largest biotech companies in the United States by net assets

Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.

Gilead Sciences leads the 20 biotech companies in the United States ranked by net assets, at SAR 85.2B, ahead of Biogen (SAR 68.5B) and Amgen (SAR 32.5B). Figures as of 20 Nov 2026, 06:46 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
20
First
Gilead SciencesSAR 85.2B
Median
SAR 6B
Combined market value
SAR 2.76T
Countries
1

Market values as of .

United States
All sectors
Biotech
SAR
Clear filters
Largest biotech companies in the United States by net assets
#CompanyNet assets ↓Market capPriceToday1 yearPrice, 30 daysCountry
1Gilead SciencesGILD · Health CareSAR 85.2BSAR 774.9BSAR 624.74 1.45% down 35% up United States
2BiogenBIIB · Health CareSAR 68.5BSAR 137BSAR 927.11 1.70% down 49% up United States
3AmgenAMGN · Health CareSAR 32.5BSAR 890.5BSAR 1,646.23 1.14% down 32% up United States
4ModernaMRNA · Health CareSAR 32.5BSAR 302.6BSAR 747.79 1.29% up 780% up United States
5Neurocrine BiosciencesNBIX · Health CareSAR 12.2BSAR 59.5BSAR 587.45 3.85% down 17% up United States
6VaxcytePCVX · Health CareSAR 10.1BSAR 34.7BSAR 218.94 0.27% down 23% up United States
7ExelixisEXEL · Health CareSAR 8.1BSAR 60.3BSAR 246.96 3.60% down 63% up United States
8Bio-TechneTECH · Health CareSAR 7.9BSAR 42.8BSAR 272.73 0.07% down 24% up United States
9RepligenRGEN · Health CareSAR 7.9BSAR 40.8BSAR 638.84 1.38% down 12% up United States
10Revolution MedicinesRVMD · Health CareSAR 6.1BSAR 129.4BSAR 598.10 0.24% down 129% up United States
11Kymera TherapeuticsKYMR · Health CareSAR 5.9BSAR 38.2BSAR 447.89 1.44% down 87% up United States
12Krystal BiotechKRYS · Health CareSAR 4.6BSAR 35.1BSAR 1,184.80 0.15% up 54% up United States
13ImmunovantIMVT · Health CareSAR 3.2BSAR 25.2BSAR 122.00 1.96% down 46% up United States
14CG OncologyCGON · Health CareSAR 2.8BSAR 27.4BSAR 307.25 2.38% up 97% up United States
15Twist BioscienceTWST · Health CareSAR 1.8BSAR 28.5BSAR 418.74 4.07% down 346% up United States
16Scholar Rock HoldingSRRK · Health CareSAR 920.9MSAR 23.1BSAR 188.96 4.94% up 26% up United States
17Adaptive BiotechnologiesADPT · Health CareSAR 820.8MSAR 17BSAR 105.23 1.44% down 74% up United States
18Kodiak SciencesKOD · Health CareSAR 590.4MSAR 24BSAR 367.27 0.09% up 399% up United States
19Halozyme TherapeuticsHALO · Health CareSAR 183.1MSAR 39.8BSAR 349.04 2.88% down 39% up United States
20ImmunityBioIBRX · Health Care-SAR 1.9BSAR 26.2BSAR 24.65 1.94% down 232% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Net assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 3.7515 SAR).

Questions and answers

Which biotech companies in the United States rank first by net assets?

Gilead Sciences (SAR 85.2B), Biogen (SAR 68.5B) and Amgen (SAR 32.5B) are the top three of the 20 biotech companies in the United States ranked by net assets as of 20 Nov 2026, 06:46 UTC.

How many biotech companies in the United States are in this ranking?

20 are ranked by net assets.

What are these biotech companies in the United States worth together?

The 20 biotech companies in the United States ranked by net assets have a combined market value of SAR 2.76T as of 20 Nov 2026, 06:46 UTC.

What does ranking by net assets measure?

Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.

Cite this page

Funkfolio, “Largest biotech companies in the United States by net assets”, data as of 20 November 2026. https://funkfolio.com/companies/category/biotech?country=united-states&by=net-assets

Underlying data: Yahoo Finance; SEC EDGAR.